CATHERINE LUKO: Open Payments
NPI 1578236303 · SMYRNA, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 13 payments from 7 companies in 2025. Trend: 2023 $749 · 2024 $385 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $145 |
| Alkermes, Inc. | 4 | $102 |
| ABBVIE INC. | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Tris Pharma Inc | 1 | $19 |
Products named: Auvelity, LYBALVI, VRAYLAR, FANAPT, CAPLYTA, ARISTADA, AUSTEDO XR, Dyanavel XR.
Industry payments across DE — which companies pay providers there.
